BioSpectrum Asia Magazine - October 2020Add to Favorites

BioSpectrum Asia Magazine - October 2020Add to Favorites

Go Unlimited with Magzter GOLD

Read BioSpectrum Asia along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99

$8/month

(OR)

Subscribe only to BioSpectrum Asia

1 Year$11.88 $7.99

Save 33% Mothers Day Sale!. ends on May 13, 2024

Buy this issue $0.99

Gift BioSpectrum Asia

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure
Payment

In this issue

E-PHARMACIES IN INDIA, MUCH MORE THAN COMMERCE
Amazon, Reliance and Flipkart v/s the others… The question is who will win? Will this pitting of wits drive new innovations in healthcare delivery and add value to customers? The COVID 19 pandemic has opened up myriad opportunities for digital platforms to tap into India’s lucrative healthcare and pharmaceutical industry. The pharma market alone is one of the largest in the world and is continuing to grow. Given the current situation, there has been a macro trend that indicates a growing need for online pharmacies as more people seek to order their medications online. Moreover, the entry of tech giant Amazon and the acquisition of Netmeds by Reliance gives a clear indication that this sector is all set for a major disruption

E-PHARMACIES IN INDIA, MUCH MORE THAN COMMERCE

Amazon, Reliance and Flipkart v/s the others… The question is who will win? Will this pitting of wits drive new innovations in healthcare delivery and add value to customers?

10+ mins

China Leads The Coronavirus Vaccine Race

Of the nine leading candidate that are under Phase III trial for the novel coronavirus in the world, five are from China- a most from any country. China has emerged as a leader in the novel coronavirus vaccines, a development that will enhance it as a global power but also raises concerns over safety and efficacy of the vaccine. Let’s look into the pros and cons of its leadership in the COVID-19 vaccine.

China Leads The Coronavirus Vaccine Race

6 mins

“We are committed to fast-tracking innovation and transformative care to patients”

Thomas Willemsen, Senior Vice President, Takeda Pharmaceuticals, APAC, Singapore

“We are committed to fast-tracking innovation and transformative care to patients”

5 mins

“We are investing in larger cleanrooms, better QA vision systems, and more technical expertise”

Oliver Healthcare Packaging, one of the leading providers of sterile barrier flexible packaging for the global healthcare industry, emphasize on custom engineered design of Sterile Barrier System (SBS) to meet medical innovations and packaging technologies. Oliver Healthcare with its state-of-the-art manufacturing facility, expanding global SBS manufacturing footprint to Asian market. Mike Benevento, President & CEO, Oliver Healthcare Packaging, Princeton, New Jersey, USA, further elaborates on the critical role of SBS and its significance as integral part of Asia Pacific (APAC) MedTech industry. Edited excerpts;

4 mins

“Indian companies are moving from API manufacturing to Formulations”

The COVID-19 pandemic has unlocked several opportunities for the life sciences sector in India. And in response to this, the sector has taken the right plunge. KPMG’s new report on ‘Site selection for life sciences in Asia’ reveals the true potential has India possess. In an interview, Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG, India expounds on the key findings of this study and shares insights on key market drivers. Edited excerpts;

“Indian companies are moving from API manufacturing to Formulations”

2 mins

‘‘We are planning to deliver products with better efficiency for APAC customers''

Francis Van Parys, Vice President Commercial, Asia Pacific, Cytiva, South Korea

‘‘We are planning to deliver products with better efficiency for APAC customers''

3 mins

Connecting the Dots

As the coronavirus pandemic rages across the globe, compounded by lockdowns, quarantine, and social distancing measures, many are turning to digital health.

Connecting the Dots

5 mins

Securing India's pharma industry from Cyber Risk

Increasing production in pharma manufacturing implies a higher convergence of IT and OT systems. While convergence between IT and OT brings about efficiency, it also expands the attacks surface. The only way to make this work safely is to have a unified, risk-based view of the IT and OT environments.

4 mins

Read all stories from BioSpectrum Asia

BioSpectrum Asia Magazine Description:

PublisherMM Activ Sci-Tech Communication

CategoryBusiness

LanguageEnglish

FrequencyMonthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All